04:30 PM EDT, 05/12/2025 (MT Newswires) -- Mark Sabag, Executive Vice President, International Markets Commercial, on May 08, 2025, sold 337,915 shares in Teva Pharmaceutical Industries ( TEVA ) for $6,097,304. Following the Form 4 filing with the SEC, Sabag has control over a total of 150,996 common shares of the company, with 150,996 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017025069132/xslF345X05/ownership.xml